211 related articles for article (PubMed ID: 35957731)
1. Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?-a narrative review.
Pellegrino A; Cirulli GO; Mazzone E; Barletta F; Scuderi S; de Angelis M; Rosiello G; Gandaglia G; Montorsi F; Briganti A; Stabile A
Ann Transl Med; 2022 Jul; 10(13):755. PubMed ID: 35957731
[TBL] [Abstract][Full Text] [Related]
2. Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.
von Hardenberg J; Borkowetz A; Siegel F; Kornienko K; Westhoff N; Jordan TB; Hoffmann M; Drerup M; Lieb V; Taymoorian K; Schostak M; Ganzer R; Höfner T; Cash H; Bruendl J;
Eur Urol Focus; 2021 Sep; 7(5):1002-1010. PubMed ID: 33877047
[TBL] [Abstract][Full Text] [Related]
3. Making a case "against" focal therapy for intermediate-risk prostate cancer.
Gontero P; Marra G; Teber D; Shariat S; Albayrak S; Coelho R; Tanguay S; Konety B
World J Urol; 2021 Mar; 39(3):719-728. PubMed ID: 32529451
[TBL] [Abstract][Full Text] [Related]
4. The prostate cancer focal therapy.
Pesapane F; Patella F; Fumarola EM; Zanchetta E; Floridi C; Carrafiello G; Standaert C
Gland Surg; 2018 Apr; 7(2):89-102. PubMed ID: 29770305
[TBL] [Abstract][Full Text] [Related]
5. Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review.
Marra G; Gontero P; Walz JC; Sivaraman A; Tourinho-Barbosa R; Cathelineau X; Sanchez-Salas R
World J Urol; 2019 Aug; 37(8):1517-1534. PubMed ID: 30710157
[TBL] [Abstract][Full Text] [Related]
6. [Focal therapy for prostate cancer in Germany - 2014 status].
Roosen A; Ganzer R; Hadaschik B; Köllermann J; Blana A; Henkel T; Liehr AB; Baumunk D; Machtens S; Salomon G; Sentker L; Witsch U; Köhrmann KU; Schostak M;
Urologe A; 2014 Jul; 53(7):1040-5. PubMed ID: 24941932
[TBL] [Abstract][Full Text] [Related]
7. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
[TBL] [Abstract][Full Text] [Related]
9. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI.
Connor MJ; Gorin MA; Ahmed HU; Nigam R
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):232-243. PubMed ID: 32051551
[TBL] [Abstract][Full Text] [Related]
10. The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series.
Stabile A; Orczyk C; Giganti F; Moschini M; Allen C; Punwani S; Cathala N; Ahmed HU; Cathelineau X; Montorsi F; Emberton M; Briganti A; Sanchez-Salas R; Moore CM
Eur Urol; 2020 Aug; 78(2):155-160. PubMed ID: 32444261
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
Borkowetz A; Blana A; Böhmer D; Cash H; Ehrmann U; Franiel T; Henkel TO; Höcht S; Kristiansen G; Machtens S; Niehoff P; Penzkofer T; Pinkawa M; Radtke JP; Roth W; Witzsch U; Ganzer R; Schlemmer HP; Grimm MO; Hakenberg OW; Schostak M
Urol Int; 2022; 106(5):431-439. PubMed ID: 35144260
[TBL] [Abstract][Full Text] [Related]
13. Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.
von Hardenberg J; Cash H; Koch D; Borkowetz A; Bruendl J; Leyh-Bannurah SR; Kuru TH; Kowalewski KF; Schindele D; Mala KS; Westhoff N; Blana A; Schostak M;
World J Urol; 2021 Oct; 39(10):3747-3754. PubMed ID: 33881557
[TBL] [Abstract][Full Text] [Related]
14. Narrative review-focal therapy: are we ready to change the prostate cancer treatment paradigm?
Williams TR; Benjamin TGR; Schwartz MJ; Rastinehad AR
Ann Transl Med; 2023 Jan; 11(1):24. PubMed ID: 36760247
[TBL] [Abstract][Full Text] [Related]
15. Surveillance following Focal Therapy interventions.
Postema AW; Catellani M; Scheltema MJ; van den Bos W; de la Rosette JJ
Arch Esp Urol; 2016 Jul; 69(6):364-74. PubMed ID: 27416640
[TBL] [Abstract][Full Text] [Related]
16. Future of focal therapy for the treatment of prostate cancer- european section of urotechnology (ESUT) position.
Barret E; Ganzer R; Salomon G; Fielder M; Celia A; Enikeev D; Martínez-Salamanca JI; Liatsikos E; Gómez Rivas J
Arch Esp Urol; 2019 Mar; 72(2):167-173. PubMed ID: 30855018
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment in focal therapy for localized prostate cancer using concomitant short-term androgen deprivation therapy: the ENHANCE prospective pilot study.
Marra G; Dell'oglio P; Baghdadi M; Cathelineau X; Sanchez-Salas R;
Minerva Urol Nefrol; 2019 Oct; 71(5):544-548. PubMed ID: 31508924
[TBL] [Abstract][Full Text] [Related]
18. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy.
Fasulo V; Cowan JE; Maggi M; Washington SL; Nguyen HG; Shinohara K; Lazzeri M; Casale P; Carroll PR
Eur Urol Oncol; 2022 Feb; 5(1):61-69. PubMed ID: 33069628
[TBL] [Abstract][Full Text] [Related]
20. [Focal therapy of prostate cancer in Germany].
Apfelbeck M; Herlemann A; Stief CG; Gratzke C
Urologe A; 2016 May; 55(5):584-92. PubMed ID: 27142799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
